Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02400515
Other study ID # 030/2007
Secondary ID
Status Completed
Phase N/A
First received March 5, 2015
Last updated March 23, 2015
Start date August 2007
Est. completion date June 2008

Study information

Verified date March 2015
Source University of Campinas, Brazil
Contact n/a
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

This quasi-experimental study aim to evaluate the effect of moderate aerobic exercise on glucose and lipid metabolism as well as the scales of anxiety and depression and levels of salivary cortisol in women with type 2 diabetes.


Description:

This quasi-experimental study aim to performed a 12-week training program (3 times/week, 60 minutes per session) which consisted of a supervised moderate aerobic exercise previously determined (50% to 70% of maximal Heart Rate) in women with type 2 diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date June 2008
Est. primary completion date March 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- having normal physical examinations,

- no participation in regular, moderate or intensive exercise for at least 6 months before the study and

- not be following a diet

Exclusion Criteria:

- the use of insulin and beta-blocker medications and

- the functional inability to perform exercise

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Exercise
This is a quasi-experimental study and the same group was evaluated before and after the exercise.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Campinas, Brazil

Outcome

Type Measure Description Time frame Safety issue
Other Salivary cortisol After practicing the exercise for 3 months, patients were submitted to a new saliva collection for the salivary cortisol measure. 3 months No
Other Hospital Anxiety and Depression scale (HADS) After 3 months of the physical exercise, the HADS was evaluated. 3 months No
Primary Glucose levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glucose test. 3 months No
Secondary Systolic and Diastolic blood pressure Change in Systolic and Diastolic blood pressure were evaluated before and after physical exercise, during 3 months. 3 months No
Secondary Heart Rate measurement Change in heart rate was evaluated before, during and after physical exercise, during 3 months. 3 months No
Secondary Glycated hemoglobin levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Glycated hemoglobin test. 3 months No
Secondary Proteinuria levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for proteinuria test. 3 months No
Secondary Triglycerides levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for triglycerides test. 3 months No
Secondary High Density Level (HDL) Cholesterol levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for High Density Level Cholesterol test. 3 months No
Secondary Low Density Level (LDL) Cholesterol levels After practicing the exercise for 3 months, patients were submitted to a new collection of blood for Low Density Level Cholesterol test. 3 months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2